ELA Medical, Inc.
ELA Medical, Inc., a prominent player in the medical device industry, is headquartered in the United States and operates extensively across various regions. Founded in 2000, the company has established itself as a leader in the development of innovative cardiac rhythm management solutions, particularly in the field of implantable devices. Specialising in advanced pacemakers and defibrillators, ELA Medical is recognised for its commitment to enhancing patient outcomes through cutting-edge technology and reliable performance. The company’s unique approach to product design and functionality has garnered significant market share and numerous accolades within the healthcare sector. With a focus on quality and innovation, ELA Medical continues to push the boundaries of cardiac care, solidifying its position as a trusted name among healthcare professionals and patients alike.
DitchCarbon Score
How does ELA Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
ELA Medical, Inc.'s score of 38 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
ELA Medical, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of LivaNova PLC, which provides emissions data cascaded from its parent organisation. However, no specific emissions figures or reduction targets have been disclosed for ELA Medical, Inc. In terms of climate commitments, ELA Medical, Inc. has not outlined any specific reduction initiatives or targets, such as those set by the Science Based Targets initiative (SBTi). The absence of detailed emissions data and reduction strategies suggests that the company may still be in the early stages of developing its climate action framework. As part of the broader industry context, it is essential for organisations like ELA Medical, Inc. to establish clear climate commitments and reduction targets to align with global sustainability goals. The lack of specific emissions data and initiatives highlights an opportunity for the company to enhance its environmental responsibility and transparency in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 7,269,000 | 0,000,000 | 000,000,000 | 00,000,000 |
| Scope 2 | 24,598,000 | 00,000,000 | - | 0,000,000 |
| Scope 3 | 59,761,000 | 00,000,000 | - | 0,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
ELA Medical, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
